PRKN and Parkinson disease: Cells expressing parkin and PINK1 mutations either coming from patients with PD or from animal models show decreased activity of oxidative phosphorylation, reduced mitochondrial respiration and mitochondrial morphological abnormalities [27,33,34,35,36].